SOPHARMA AD

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 11 / 2020

Date of issue: 2020-04-29

Short name of the issuer

SOPHARMA AD

Subject

Publishing of the Consolidated Audited Financial Statements for 2019 made public in the terms envisaged in §45, item 2 of the TAP of the Law for the measures and actions under extraordinary circumstances

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, April 6, 2020 – “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the Consolidated Audited Financial Statements for 2019 will be made public in the terms envisaged in §45, item 2 of the TAP of the Law for the measures and actions under extraordinary circumstances. The delayed publishing of the Report is due to the extraordinary conditions in a number of countries in which the companies from the Group operate. Measures have been taken within the Company to decrease to a maximum the timeframe for finalizing and publishing of all documents part of the Report.

Annexes

File Description

3JR_Consolidated_Audited_Extended_espi.pdf Publishing of the Consolidated Audited Financial Statements for 2019 made public in the terms envisaged in §45, item 2 of the TAP of the Law for the measures and actions under extraordinary circumstances

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2020-04-29 Ognian Donev Executive Director